2-n,n-di-n-propylamino-4,7-dimethoxyindan has been researched along with haloperidol in 1 studies
Studies (2-n,n-di-n-propylamino-4,7-dimethoxyindan) | Trials (2-n,n-di-n-propylamino-4,7-dimethoxyindan) | Recent Studies (post-2010) (2-n,n-di-n-propylamino-4,7-dimethoxyindan) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
---|---|---|---|---|---|
16 | 0 | 0 | 20,330 | 1,753 | 3,294 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnerić, SP; Long, JP | 1 |
1 other study(ies) available for 2-n,n-di-n-propylamino-4,7-dimethoxyindan and haloperidol
Article | Year |
---|---|
Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions.
Topics: Animals; Atropine Derivatives; Blood Pressure; Brain; Drug Interactions; Haloperidol; Heart Rate; Hemodynamics; Indans; Indenes; Injections, Intravenous; Injections, Intraventricular; Male; Phentolamine; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1984 |